USE OF TRANSFORMING GROWTH FACTOR - BETA 1 (TGF-B1) INHIBITOR PEPTIDES FOR THE TREATMENT OF CORNEAL FIBROSIS AND/OR HAZE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120315256A1
SERIAL NO

13580103

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention refers to the use of transforming growth factor-beta 1 (TGF-β1) inhibitor peptides or polynucleotides encoding said peptides for the prevention and/or treatment of corneal fibrosis and/or corneal haze.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DIGNA BIOTECH S LPAMPLONA PAMPLONA NAVARRE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dotor, De Las Herrerias Javier Pamplona - Navarra, ES 5 6
Maldonado, Lopez Miguel Jose Pamplona - Navarra, ES 1 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation